Allylbenzene Metabolism
Allylbenzene metabolism involves multiple pathways, including Phase I oxidation by CYP450 enzymes and Phase II Glycine Conjugation, which compete with the proposed formation of alkaloid metabolites. The availability of amino acids can influence which metabolic pathways are utilized [1].
Phase I Metabolism
Allylbenzenes undergo Phase I metabolism, which typically involves 1'-hydroxylation to an allyl alcohol derivative, followed by oxidation to an aldehyde metabolite, and further oxidation to a carboxylic acid metabolite [1]. This process is mediated by CYP450 enzymes, primarily CYP1A2 and CYP3A4 [2][3]. CYP1A2 is noted as the primary enzyme for myristicin metabolism, converting it to 5-allyl-1-methoxy-2,3-dihydroxybenzene [3]. CYP3A4 is a secondary pathway and the most prevalent CYP enzyme in the human liver [3].
Phase II Metabolism: Glycine Conjugation
Glycine conjugation is identified as a major competing pathway for allylbenzene metabolism [1]. Aldehyde metabolites of allylbenzenes can undergo glycine conjugation to increase their water solubility and facilitate urinary excretion [1]. This process is a two-step enzymatic pathway that occurs in the mitochondrial matrix [4]:
1. **Acyl-CoA formation:** Mediated by medium-chain acyl-CoA synthetase 2B (ACSM2B), also known as xenobiotic/medium-chain fatty acid CoA ligase. This enzyme activates the carboxylic acid metabolite to a CoA thioester, requiring ATP, CoA, and Mg2+ [4].
2. **Conjugation:** Catalyzed by Glycine N-Acyltransferase (GLYAT), which transfers the acyl group from the CoA thioester to glycine [4].
Glycine is the most frequently used amino acid for xenobiotic conjugation in humans, particularly for aromatic carboxylic acids [4][1]. Its availability can be limited, which may affect the extent of this reaction [1]. Other amino acids like glutamine and taurine can also be involved in conjugation in humans, though glutamine plays a minor role in allylbenzene metabolism [4].
Predicted glycine conjugates for specific allylbenzenes include:
- **Methylchavicol (estragole):** Documented metabolites include 4-methoxycinnamoylglycine and 4-methoxybenzoyl-N-glycine [1].
- **Sarisan:** Predicted to form 3,4-methylenedioxy-5-methoxycinnamoylglycine and 3,4-methylenedioxy-5-methoxybenzoyl-N-glycine [1].
- **Croweacin:** Predicted to form 2-methoxy-3,4-methylenedioxycinnamoylglycine and 2-methoxy-3,4-methylenedioxybenzoyl-N-glycine [1].
- **Isoelemicin:** Predicted to form 3,4,5-trimethoxycinnamoylglycine and 3,4,5-trimethoxybenzoyl-N-glycine [1].
- **Osmorhizole:** Expected to follow the pattern of forming [substituent groups]-cinnamoylglycine and [substituent groups]-benzoyl-N-glycine [1].
Alkaloid Formation (VKFRI Hypothesis)
Within the Institute's framework, VKFRI proposes that allylbenzenes can be metabolized into alkaloid compounds [1]. This process is described as part of the "Oilahuasca theory," which suggests that allylbenzenes are pro-drugs requiring metabolic activation [2][5].
The proposed pathway involves:
1. **CYP450-mediated oxidation:** Allylbenzenes (e.g., myristicin, elemicin, safrole) are converted by CYP450 enzymes (primarily CYP1A2, CYP3A4) to 1'-hydroxy metabolites [2].
2. **Further oxidation:** The 1'-hydroxy metabolites are further oxidized to 1'-oxo metabolites, which are described as reactive intermediates [2].
3. **Non-enzymatic adduct formation:** These 1'-oxo intermediates then undergo non-enzymatic condensation with endogenous amines, such as dimethylamine, piperidine, and pyrrolidine [2][6].
The resulting alkaloid metabolites are identified as aminopropiophenones, not amphetamines [1]. Three subtypes of these alkaloid metabolites are proposed: dimethylamines, piperidines, and pyrrolidines [1]. VKFRI hypothesizes that only allyl forms of these compounds, not propenyl forms, are capable of forming these alkaloid metabolites [1]. Glycine depletion could theoretically enhance the formation of these alkaloids [1].
Specific Allylbenzenes and Activity
The presence of specific substituent groups on the benzene ring is proposed to influence the activity of allylbenzenes [7]:
- **Allyl side chain:** Required for alkaloid conversion [7].
- **Position 4:** Must be a methoxy or methylenedioxy group for psychedelic activity; a hydroxy group at this position (as in eugenol or chavicol) results in stimulant, not psychedelic, activity [7].
- **Position 2:** A methoxy group here may lead to LSD-like mental effects [7].
- **Position 5:** Methoxy or methylenedioxy groups may enhance visuals [7].
- **Position 6:** A methoxy group here may lead to amphetamine-style speedy effects [7].
Examples of allylbenzenes mentioned in the context of metabolism or activity include:
- Myristicin (from nutmeg, parsley) [2][3][7]
- Elemicin (from nutmeg) [2][7]
- Safrole (from sassafras, trace in nutmeg) [2][7]
- Estragole (methylchavicol, from basil, fennel) [1][6]
- Apiole (from parsley) [8][7]
- Dillapiole (from dill) [6][7]
- Methyl eugenol (from bay, allspice) [6][7]
- Sarisan [1][7]
- Croweacin [1][7]
- Isoelemicin [1]
Sources
- oilahuasca/oilahuasca/neurogenesis_synaptogenesis_endocannabinoid_deep_dive.json
- oilahuasca/oilahuasca/oilahuasca_allylbenzene_metabolism_complete.json
- oilahuasca/oilahuasca/oilahuasca_allylbenzene_research_compilation.json
- oilahuasca/oilahuasca/oilahuasca_amino_acid_metabolism.json
- oilahuasca/oilahuasca/oilahuasca_complete_research_synthesis.json
- oilahuasca/oilahuasca/oilahuasca_comprehensive_theory.json
- oilahuasca/oilahuasca/oilahuasca_comprehensive_theory_part2.json
- oilahuasca/oilahuasca/oilahuasca_core_principles.json
- oilahuasca/oilahuasca/oilahuasca_dmtnexus_69ron_thread.json
- oilahuasca/oilahuasca/oilahuasca_dmtnexus_space_booze_thread.json
- oilahuasca/oilahuasca/oilahuasca_experience_reports.json
- oilahuasca/oilahuasca/oilahuasca_herb_analysis.json
- oilahuasca/oilahuasca/oilahuasca_marsresident_research.json
- oilahuasca/oilahuasca/oilahuasca_mechanistic_model.json
- oilahuasca/oilahuasca/oilahuasca_phase2_metabolism.json
- oilahuasca/oilahuasca/oilahuasca_practical_formulations.json
- oilahuasca/oilahuasca/oilahuasca_safety_profile.json
- oilahuasca/oilahuasca/oilahuasca_sources.json
- oilahuasca/oilahuasca/oilahuasca_space_paste_recipe.json
- oilahuasca/oilahuasca/oilahuasca_theory.json
- psychedelics/psychedelics/cyp450_enzyme_database.json
- psychedelics/psychedelics/enzymatic_alchemy_consciousness.json
- psychedelics/psychedelics/wellbutrin_cyp450_forum_thread.json
- shulgin-pihkal-tihkal
Coverage
The section "Specific Allylbenzenes and Activity" is primarily based on a single source, `oilahuasca_marsresident_research.json`, for the proposed influence of substituent groups on activity. The "Alkaloid Formation (VKFRI Hypothesis)" section draws heavily from VKFRI's internal research and the "Oilahuasca theory" documents.
References
oilahuasca_allylbenzene_metabolism_complete.jsonoilahuasca_allylbenzene_research_compilation.jsonoilahuasca_complete_research_synthesis.jsonoilahuasca_amino_acid_metabolism.jsonoilahuasca_theory.jsonoilahuasca_mechanistic_model.jsonoilahuasca_marsresident_research.jsonoilahuasca_herb_analysis.json